Design And Analysis Of Cross Over Trials Second Edition

Download Design And Analysis Of Cross Over Trials Second Edition full books in PDF, epub, and Kindle. Read online free Design And Analysis Of Cross Over Trials Second Edition ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!

Design and Analysis of Cross-Over Trials, Second Edition

Design and Analysis of Cross-Over Trials, Second Edition
Author :
Publisher : CRC Press
Total Pages : 390
Release :
ISBN-10 : 9781420036091
ISBN-13 : 1420036092
Rating : 4/5 (092 Downloads)

Book Synopsis Design and Analysis of Cross-Over Trials, Second Edition by : Byron Jones

Download or read book Design and Analysis of Cross-Over Trials, Second Edition written by Byron Jones and published by CRC Press. This book was released on 2003-03-12 with total page 390 pages. Available in PDF, EPUB and Kindle. Book excerpt: The first edition of Design and Analysis of Cross-Over Trials quickly became the standard reference on the subject and has remained so for more than 12 years. In that time, however, the use of cross-over trials has grown rapidly, particularly in the pharmaceutical arena, and researchers have made a number of advances in both the theory and methods applicable to these trials. Completely revised and updated, the long-awaited second edition of this classic text retains its predecessor's careful balance of theory and practice while incorporating new approaches, more data sets, and a broader scope. Enhancements in the second edition include: A new chapter on bioequivalence Recently developed methods for analyzing longitudinal continuous and categorical data Real-world examples using the SAS system A comprehensive catalog of designs, datasets, and SAS programs available on a companion Web site at www.crcpress.com The authors' exposition gives a clear, unified account of the design and analysis of cross-over trials from a statistical perspective along with their methodological underpinnings. With SAS programs and a thorough treatment of design issues, Design and Analysis of Cross-Over Trials, Second Edition sets a new standard for texts in this area and undoubtedly will be of direct practical value for years to come.


Design and Analysis of Cross-Over Trials, Second Edition Related Books

Design and Analysis of Cross-Over Trials, Second Edition
Language: en
Pages: 390
Authors: Byron Jones
Categories: Mathematics
Type: BOOK - Published: 2003-03-12 - Publisher: CRC Press

DOWNLOAD EBOOK

The first edition of Design and Analysis of Cross-Over Trials quickly became the standard reference on the subject and has remained so for more than 12 years. I
Cross-over Trials in Clinical Research
Language: en
Pages: 364
Authors: Stephen S. Senn
Categories: Mathematics
Type: BOOK - Published: 2003-07-25 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Cross-over trials are an important class of design used in the pharmaceutical industry and medical research, and their use continues to grow. Cross-over Trials
Design and Analysis of Cross-Over Trials
Language: en
Pages: 431
Authors: Byron Jones
Categories: Mathematics
Type: BOOK - Published: 2014-10-08 - Publisher: CRC Press

DOWNLOAD EBOOK

Design and Analysis of Cross-Over Trials is concerned with a specific kind of comparative trial known as the cross-over trial, in which subjects receive differe
Design and Analysis of Cross-Over Trials, Second Edition
Language: en
Pages: 412
Authors: Byron Jones
Categories: Mathematics
Type: BOOK - Published: 2003-03-12 - Publisher: CRC Press

DOWNLOAD EBOOK

The first edition of Design and Analysis of Cross-Over Trials quickly became the standard reference on the subject and has remained so for more than 12 years. I
Clinical Trials in Neurology
Language: en
Pages: 387
Authors: Bernard Ravina
Categories: Medical
Type: BOOK - Published: 2012-04-12 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

Translating laboratory discoveries into successful therapeutics can be difficult. Clinical Trials in Neurology aims to improve the efficiency of clinical trials